GSK PLC closed 30.68% below its 52-week high of £18.24, which the company achieved on May 16th.

With 48 hedge funds owning the stock, GSK is one of the best ADR stocks to buy. Overall GSK ranks 12th on our list of the 12 ...

Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...

Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

GSK has three segments ... For more than a quarter century, the Zacks Rank stock-rating system has more than doubled the S&P 500 with an average gain of +24.08% per year. (These returns cover ...

Learn more about whether Corcept Therapeutics Incorporated or GSK plc is a better investment based on AAII's A+ Investor ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

A study of over 280,000 adults found that the shingles vaccine reduced dementia risk by 20%, with a stronger effect in women.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK ...

GSK PLC closed 26.98% short of its 52-week high of £18.24, which the company reached on May 16th.

With 48 hedge funds owning the stock, GSK is one of the best ADR stocks to buy. Overall GSK ranks 12th on our list of the 12 best ADR stocks to buy according to hedge funds. While we acknowledge ...